OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-12-31-accounts

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

Charity Number: 1176307

The ecancer Global Foundation FINANCIAL STATEMENTS

For the Year Ended 31 December 2021

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The ecancer Global Foundation FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

C O N T E N T S
Page
LEGAL AND ADMINISTRATIVE DETAILS 1
TRUSTEES’ REPORT 2 - 5
INDEPENDENT EXAMINERS’ REPORT 6
STATEMENT OF FINANCIAL ACTIVITIES 7
BALANCE SHEET 8
NOTES TO THE FINANCIAL STATEMENTS
9-13

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The ecancer Global Foundation FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

Principal address The ecancer Global Foundation 13 King Square Avenue Bristol BS2 8HU Independent Examiners Hazlewoods LLP Windsor House Bayshill Road Cheltenham GL50 3AT

Trustees:

The trustees who served during the year were:

Emily Sarah Kobbe Penelope Jane Crocker Professor Richard Sullivan James Isola Cristian Herra (appointed 1 June 2022) Groesbeck Parham (appointed 1 June 2022)

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The e cancer Global Foundation TRUSTEES’ REPORT FOR THE YEAR ENDED 31 DECEMBER 2021

Message from the chair

2021 has been a year of uncertainty for the world as society manages a return to a new normal in coping with the ongoing pandemic. The global oncology community, including ecancer, are not immune to these circumstances, as such, 2021 has been a year of tentatively edging towards pre-pandemic activity where appropriate.

One of the biggest challenges for ecancer is to maintain the momentum in terms of the increased interest in online learning during the heights of the pandemic. Our overall engagement with healthcare professionals through ecancer.org has dipped by 2% over the year but, based on the significant increase in 2020, we are Prof Richard Sullivan satisfied with the result .

2021 was the first full year of the new submission criteria for our Journal, ecancermedicalscience, where we proactively support the publication of research from Low- and Middle- Income Countries (LMICs) and other resource limited settings. Therefore, it was gratifying to see that we only experience a 1% drop in the number of articles publish when compared to 2020.

In 2022, we’re looking forward to the return of international travel which will hugely impact our Video and Events Teams who will be able to attend global conferences as well as running face to face events respectively. Towards the end of 2021 we secured funding which will allow a significant increase in the number of events we will run and the number of online resources we can provide specifically to support oncology professionals in LMICs. This is hugely exciting for the organisation and means that we can look forward positively to making a positive impact on the education of the global oncology community.

As always, we are hugely appreciative to the individuals and organisations who we work with to improve care for cancer patients across the world. Without their support our work would not be possible and we are forever mindful of this.

Prof Richard Sullivan – Chair of Trustees

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The e cancer Global Foundation TRUSTEES’ REPORT CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2021

Report of the Trustees

The Trustees hereby present the statutory report, with the accounts of The ecancer Global Foundation, for the year ending 31 December 2021.

The results for the year are presented in the form of a Statement of Financial Activities, which incorporates the traditional income and expenditure account, in order to comply with the Statement of Recommended Practice for Charities, and in accordance with the Charities Act 2011.

The Trust

The accounts accompanying this report are the accounts of the charitable trust. It is registered with the Charities Commission, Charity Registration number 1176307.

Charitable objectives

Our vision

A world in which every cancer patient receives the best possible care and treatment.

Our mission and future plans

e cancer's mission is to raise the standards of care for cancer patients across the world through education. Throughout the next 12 months, the charity will focus on managing the post Brexit process, as well as managing the transition to a post COVID world. The charity also aims to build on the success of 2021 and to increase the levels of income while effectively managing expenditure.

Another key future plan for the charity is to recruit the first Individual Giving Fundraiser and develop a comprehensive fundraising strategy.

Public benefit statement:

The ecancer Global Foundation’s charitable purpose is carried out for the public benefit in accordance with our vision and mission. The Trustees confirm that they have complied with the duty in Section 17 of the Charities Act 2011 to have due regard to the Charity Commission’s general guidance on Charities and Public Benefit.

Educational activities for healthcare professionals

The majority of the oncology professionals who engage with our educational resources do so through our open access and free website, ecancer.org. The site provides a vast knowledge bank covering every cancer type which are developed in partnership with leading global experts to meet regional educational needs. ecancer.org has been publishing free education for the oncology community since 2007 and, as such, has an established audience from around the world.

As well as ecancer.org, our ethos is to provide educational resources to the global oncology community wherever there is a need to as wide an online audience as possible. Our resources are therefore also disseminated through platforms such as YouTube, PubMed, Twitter, Facebook, LinkedIn, Scopus, Web of Science, Embase, EBSCO and Google Scholar as well as other educational partners such as the Union for International Cancer Control (UICC), the International Cancer Control Partnership and the International Society for Geriatric Oncology (SIOG).

A section of ecancer.org is dedicated to healthcare professionals in Latin America with content in predominantly in Spanish but also in Portuguese. We have native Spanish speakers who manage and maintain this section with support from our other team members.

We also publish ecancerpatient.org which is a patient-focused website that provides the latest cancer information direct from experts in an easy-to-understand format that was developed in partnership with patient groups. The goal is to empower patients to be more involved in the decision-making process when it comes to their care.

Our series of educational events in under-served areas of the world is now well established in Latin America and has launched in India with fantastic educational partners allowing us to deliver high quality education in areas of the world that need it most.

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The e cancer Global Foundation TRUSTEES’ REPORT CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2021

Key 2021 highlights (figures in brackets show change from 2020) ecancer.org

Video

Journal (ecancermedicalscience)

-402 (↓16%) submitted articles in English and Spanish

-177 published articles (↓1%) with translations if required

e-learning

News

-2,067 (1,657 in English and 410 in Spanish) stories were published from leading oncology sources (↓3%) -Our news stories were read 444,120 times (↑27%)

-We are partners in projects funded by the Medical Research Council and the Innovative Medicines Initiative:

Events

-We ran six events (↑20%). Six virtual events were held in collaboration with regional and international partners including the Union for International Cancer Control (UICC),

Sociedad Lationamericana y del Caribe de Oncologia Medica (SLACOM), Liga Colombiana Contra el Cancer and the National Cancer Grid of India.

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The e cancer Global Foundation TRUSTEES’ REPORT CONTINUED FOR THE YEAR ENDED 31 DECEMBER 2021

Trustee Recruitment and training programme

The existing Trustees and CEO review any gaps in the group of Trustees on an ongoing basis, and if there is a shortage, will review suitable individuals who fit the requirements profile. Any individual is then approached and recruited, and follows the charity’s training and induction process.

Pay and remuneration is reviewed on an annual basis as part of the budgeting process, and is agreed at Trustee level.

Decision making

The charity is managed by the CEO, with support from the Senior Management Team. Key decisions likely to significantly impact the organisation are agreed by the CEO and Trustees, who review and evaluate in detail.

Risk Assessment

In accordance with the SORP requirements, the Trustees carry out wide-ranging reviews of the risks faced by the charity. These reviews look particularly at Health and Safety issues, management and financial accountability and internal security. The Trustees are satisfied that all appropriate and feasible measures have been put in place to reduce the risks to which the charity is exposed. As a consequence of this, the Trustees have greater awareness of the kinds of risks which could affect the charity and have implemented strategies to reduce such risks.

Reserves policy and financial position

As a young charity, we are currently in the process of building reserves to achieve the aims of the organisation which is to maintain free unrestricted reserves:

STATEMENT OF TRUSTEES’ RESPONSIBILITIES

The Trustees of the Charity are required to prepare for each financial year accounts which give a true and fair view of the state of affairs of the Charity and of the incoming resources and application of resources of the Charity for that period. In preparing those financial statements, the trustees are required to:

The Trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the Charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the Trust Deed dated 5 June 1956. They are also responsible for safeguarding the assets of the Charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 11/11/2022

Approved by the Trustees on …………..…… and signed as authorised

…………………………….. Prof. Richard Sullivan

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The ecancer Global Foundation INDEPENDENT EXAMINERS’ REPORT TO THE DIRECTORS OF THE TRUSTEE COMPANY FOR THE YEAR ENDED 31 DECEMBER 2021

I report on the accounts of The e cancer Global Foundation for the year ended 31 December 2021, which are set out below.

Respective responsibilities of trustees and examiner

The trustees are responsible for the preparation of the accounts. The trustees consider that an audit is not required for this year (under section 144 of the Charities Act 2011 (the Act)) and that an independent examination is needed. It is my responsibility to:

Basis of independent examiners’ report

My examination was carried out in accordance with the General Directions given by the Charity Commission. An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts and seeking explanations from the trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently no opinion is given as to whether the accounts present a ‘true and fair’ view and the report is limited to those matters set out in the statement below.

Independent examiners’ statement

In connection with my examination, no material matter has come to my attention which gives me cause to believe that, in any material respect:

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

……………………………… Martin Howard FCA

11/11/2022

Date: ……………..

Hazlewoods LLP Chartered Accountants

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The e cancer Global Foundation STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2021

INCOMING
RESOURCES
Unrestricted
funds
Notes
Donations and
legacies
Charitable
Activities
E-learning
Events
Journal
Research projects
Educational video
Website
Other Activities to
Generate
Funds
Advertising income
Total Incoming
Resources
Resources
Expended
Raising funds
Charitable
Expenditure
E-learning
Events
Journal
Research projects
Educational videos
Website
Advertising
Total Resources
Expended
2
Net movements in
funds
Transfer between
funds
Total funds
brought forward
Balance carried
forward at 31
December 2021		 Unrestricted
funds
2021
£
254
43,713
11,130
20,997
-
374,832
22,900
52,876
526,702
57,881
3,009
26,754
96,173
-
184,870
65,829
411
192,965
434,927
91,775
20,932
43,205
155,912		 Restricted
funds
2021
£
-
67,209
-
-
-
294,927
-
-
362,136
-
73,459
30,756
-
-
224,419
-
-
328,634
328,634
33,502
(20,932)
15,813
28,383		 Total
funds 2021
£
254
110,922
11,130
20,997
-
669,759
22,900
52,876
888,838
57,881
76,468
57,510
96,173
-
409,289
65,829
411
521,599
763,561
125,277
-
59,018
184,295		 Total funds
2020
£
1,185
106,556
65,180
20,346
41,144
725,156
-
71,178
1,030,745
-
102,686
139,828
72,550
35,643
493,428
-
-
844,136
844,136
186,609
-
(127,591)
59,018

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The ecancer Global Foundation BALANCE SHEET AT 31 DECEMBER 2021

Note
Fixed assets
3,7
Current Assets
Debtors and prepayments
4,7
Cash at bank and in hand
Less Creditors: Amounts
falling due within one year
5,7
Net Current Assets
Net Assets
Represented by:
Unrestricted funds:
6
Restricted funds
6		 2021
2,245
183,455
595,745
779,200
(597,150)
182,050
184,295
155,912
28,383
184,295		 2020
£
2,063
145,770
158,515
304,285
(247,330)
56,955
59,018
43,205
15,813
59,018

11/11/2022

Approved by the trustees on ………………. and signed on their behalf by:

………………….. Prof R Sullivan

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The ecancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

1. Accounting Policies

Basis of Preparation

The financial statements have been prepared under the historical cost convention, as modified by the revaluation of certain fixed assets, adopting the following principal accounting policies all of which are in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) and the Charities Act 2011.

General information

The financial statements are presented in Pounds Sterling. The charity is a public benefit charitable incorporated organisation, incorporated in England and Wales.

The address of its registered office is: 13 King Square Avenue Bristol BS2 8HU

Judgements and estimation uncertainty

The trustees consider that there are no key areas of judgement or estimation uncertainty to be disclosed in these financial statements.

Tangible fixed assets and depreciation

Tangible fixed assets are stated in the accounts at cost or revalued amount less depreciation. Depreciation is provided at rates calculated to write off the cost of each asset over its expected useful life.

Depreciation is provided to write off the cost/value of assets over their useful lives as follows:

Office equipment 5 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade receivables

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All debtors are repayable within one year and are hence included at the undiscounted amount of the cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the Charity will not be able to collect all amounts due according to the original terms of the receivables.

Trade payables

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the Charity does not have an unconditional right, at the end of the reporting year, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

Legacies, Donations and Grants Receivable

All income is recognised when receivable and when capable of financial measurement. Receipts of property investments or other gifts in king are included at market value.

Going concern

There are no significant factors affecting the charity’s ability to continue as a going concern.

Expenditure on Charitable activities

Expenditure on Charitable activities is included in the Statement of Financial Activities on an accruals basis. Where expenditure is directly attributable to more than one activity, it is apportioned across cost categories on the basis of the proportion of income receivable relating to each activity.

Funds

Funds held by the charity are either:

Pensions

The company operates a defined contribution scheme for certain employees. The contributions are charged to revenue in the year in which they are incurred.

2. Analysis of Total Resources Expended

Charitable Expenditure
E-learning
Events
Journal
Research projects
Educational videos		 Direct
Activities
£
-
-
81,785
-
-
81,785		 Grant
funding
£
70,744
66,117
-
23,264
242,831
402,956		 Support
costs
(see 2a
below) £
5,724
5,604
14,388
3,121
48,209
77,046		 2021
Total
£
76,468
71,721
96,173
26,385
291,040
777,774		 2020
Total
£
121,075
145,396
123,882
42,680
411,103
844,136

Support costs are allocated on the basis of full-time equivalents.

Staff costs:
Wages and salaries
Social security costs
Pension costs
The average number of full time employees
In the period was		 2021
£
470,796
39,880
34,992
545,668
Number
18		 2020
£
451,355
37,347
35,670
524,372
Number
17

No employee earned £60,000 or more, and no Trustees were remunerated through the charity.

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The ecancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

2a. Analysis of Support Costs

Raising funds
E-learning
Events
Journal
Research projects
Educational videos		 2021
£
-
5,724
5,604
14,388
3,121
48,209
77,046		 2020
£
-
9,063
11,361
18,534
5,049
68,097
112,104

Support costs are all allocated to charitable expenditure, other than £nil (2020 - £nil) incurred in relation to raising funds within the year.

Independent examination fees accrued during the year was £3,000, (2021 - £6,000 audit fees). No other services were provided by the auditors.

3. Fixed assets

Cost
At 1 January 2021
Additions
December 31, 2021
Depreciation
At 1 January 2021
Charge for the year
December 31, 2021
Net book value
December 31, 2021
December 31, 2020
.
Debtors
Trade debtors
Prepayments and accrued income		 Office
equipment
£
2,556
812
3,368
493
630
1,123
2,245
2,063
2021
£
179,548
3,907
183,455		 Total
£
2,556
812
3,368
493
630
1,123
2,245
2,063
2020
£
64,483
81,287
145,770

4. Debtors

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The e cancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

5. Creditors: Amounts falling due within one year

Trade creditors
Taxation and social security
Accruals and deferred income
Other creditors		 2021
£
7,684
11,685
568,086
9,695
597,150		 2020
£
23,516
10,391
207,818
5,605
247,330

Included within accruals and deferred income is £565,086 (2020 - £199,718) in relation to income deferred on performance-related grants. These grants are considered to contain conditions that require the charity to undertaken certain activities before it becomes fully entitled to the respective grant monies.

Reconciliation of deferred income

At 1 January 2021
Deferred income released
Additional deferred income
At 31 December 2021		 Deferred income
£
199,718
(216,640)
582,008
565,086

6. Funds

General fund
Restricted
fund
E-learning
Events
Journal
Research
Educational
videos
Transfer
between funds		 1 January
2021
£
43,205
-
-
-
5,501
10,312
-
59,018		 Incoming
resources
£
526,702
67,209
-
-
-
294,927
-
888,838		 Transfer
between
funds
£
20,932
6,250
30,756
-
-
(57,938)
-
-		 Outgoing
resources
£
(434,927)
(73,459)
(30,756)
-
-
(224,419)
-
(777,774)		 31 December
2021
£
155,912
-
-
5,501
22,882
-
-
184,295

The restricted funds are held separately as they relate to specific performance related grant funds and expenditure. They represent various projects for which the donors have specified the use of the funds. These have been grouped into various categories for the purpose of the note above.

A transfer has been made between the funds to correct amounts incorrectly treated in the prior year, as well as to clear out negative restricted fund balances at year end, and move the deficit back to general funds.

DocuSign Envelope ID: 236F66CC-C26F-4265-ACA0-6DDC20C24CDC

The e cancer Global Foundation NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

7. Reconciliation of funds per asset/liability

Fixed assets
Cash at bank and
in hand
Current assets
Current liabilities
Fixed assets
Cash at bank and
in hand
Current assets
Current liabilities		 Unrestricted
funds
£
2,245
595,745
183,456
(31,299)
750,147
Unrestricted
funds
£
2,063
158,515
66,370
(47,612)
179,336		 Restricted
funds
£
-
-
-
(565,806)
(565,806)
Restricted
funds
£
-
-
79,400
(199,718)
(120,318)		 2021
Total
£
2,245
595,745
183,456
(597,105)
184,341
2020
Total
£
2,063
158,515
304,284
(247,330)
59,018

8. Related party transactions

The charity has no related party transactions to disclose.